Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center

Recurrent hepatitis C (HCV) after liver transplantation (LT) is an important cause of morbidity and mortality. Antiviral treatment is recommended to avoid unfavorable outcomes. Direct-acting antivirals (DAA) have transformed HCV treatment, with higher efficacy and fewer side-effects than interferon-...

Full description

Bibliographic Details
Main Authors: L.P. Zanaga, A.G. Santos, E.C. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000800606&lng=en&tlng=en